Line 9: |
Line 9: |
| ==What is Fluid Therapy?== | | ==What is Fluid Therapy?== |
| '''Fluid Therapy''' is the administration of fluids to a patient as a treatment or preventative measure. It can be administered via an intravenous, intraperitoneal, intraosseous, subcutaneous and oral routes. 60% of total bodyweight is accounted for by the total body water. This can further be divided into intracellular or extracellular as shown below. | | '''Fluid Therapy''' is the administration of fluids to a patient as a treatment or preventative measure. It can be administered via an intravenous, intraperitoneal, intraosseous, subcutaneous and oral routes. 60% of total bodyweight is accounted for by the total body water. This can further be divided into intracellular or extracellular as shown below. |
− |
| |
| [[Image:Body_Compartments.jpg|center|]] | | [[Image:Body_Compartments.jpg|center|]] |
| | | |
| Fluid therapy is indicated either when there is a loss of fluid to any part of these compartments or there is a risk of loss of fluid. The severity of the fluid loss, and the compartment which is has been lost from with influence the choice of fluid and the speed at which it needs to be administered. If fluid therapy is performed as a treatment then it is necessary to diagnose and treat the underlying condition. | | Fluid therapy is indicated either when there is a loss of fluid to any part of these compartments or there is a risk of loss of fluid. The severity of the fluid loss, and the compartment which is has been lost from with influence the choice of fluid and the speed at which it needs to be administered. If fluid therapy is performed as a treatment then it is necessary to diagnose and treat the underlying condition. |
− |
| |
| ===Indications=== | | ===Indications=== |
| *Hypotension | | *Hypotension |
Line 44: |
Line 42: |
| ==Fluid Rate Calculations== | | ==Fluid Rate Calculations== |
| When calculating the fluid requirements of a patient, there are 3 elements to consider - | | When calculating the fluid requirements of a patient, there are 3 elements to consider - |
− |
| |
| # Replacement | | # Replacement |
| # Maintainance | | # Maintainance |
| # Ongoing Losses | | # Ongoing Losses |
− |
| |
| ''Replacements'' are calculated based on the level of dehydration. Dehydration is based upon clinical assessment of each individual patient. Most commonly, skin tent is used for assessment. To calculate the amount required for replacement within a 24 hour period, the percentage dehydration is used in the following calculation. | | ''Replacements'' are calculated based on the level of dehydration. Dehydration is based upon clinical assessment of each individual patient. Most commonly, skin tent is used for assessment. To calculate the amount required for replacement within a 24 hour period, the percentage dehydration is used in the following calculation. |
− |
| |
− |
| |
| <center> | | <center> |
| {| border="1" cellpadding="1" | | {| border="1" cellpadding="1" |
Line 59: |
Line 53: |
| |} | | |} |
| </center> | | </center> |
− |
| |
| | | |
| ''Maintainance'' is the basic rate which a patient requires during a 24 hour period. It is commonly calculated as 50ml/kg/24hr, or 2ml/kg/hr. | | ''Maintainance'' is the basic rate which a patient requires during a 24 hour period. It is commonly calculated as 50ml/kg/24hr, or 2ml/kg/hr. |
− |
| |
| | | |
| ''Ongoing losses'' are calculated based on a predicted fluid amount lost by a patient within a 24 hour period. Common losses include vomitting and diarrhoea. It is often helpful here if the owners are able to give a detailed history as this makes it easier to predict the pattern of losses. In some patients there may be no ongoing losses and so this step can be skipped. To calculate the fluid requirement, the following calculation is used. | | ''Ongoing losses'' are calculated based on a predicted fluid amount lost by a patient within a 24 hour period. Common losses include vomitting and diarrhoea. It is often helpful here if the owners are able to give a detailed history as this makes it easier to predict the pattern of losses. In some patients there may be no ongoing losses and so this step can be skipped. To calculate the fluid requirement, the following calculation is used. |
− |
| |
− |
| |
| <center> | | <center> |
| {| border="1" cellpadding="1" | | {| border="1" cellpadding="1" |
Line 74: |
Line 64: |
| |} | | |} |
| </center> | | </center> |
− |
| |
| | | |
| These calculations are then added together to allow for the total fluid requirement in a 24 hour period. It is important to assess these requirements on a daily basis as losses may be increased/reduceed for example. | | These calculations are then added together to allow for the total fluid requirement in a 24 hour period. It is important to assess these requirements on a daily basis as losses may be increased/reduceed for example. |
− |
| |
| | | |
| The calculated fluid requirement is multiplied by the bodyweight of the individual patient to give the total amount of fluid required for that patient as ml/24hr period. This is then further calculated depending on whether a drip pump is used or fluid rate is adjusted manually as shown below. | | The calculated fluid requirement is multiplied by the bodyweight of the individual patient to give the total amount of fluid required for that patient as ml/24hr period. This is then further calculated depending on whether a drip pump is used or fluid rate is adjusted manually as shown below. |
− |
| |
| <center> | | <center> |
| {| border="1" cellpadding="1" | | {| border="1" cellpadding="1" |
Line 99: |
Line 86: |
| ==Monitoring Fluid Therapy== | | ==Monitoring Fluid Therapy== |
| Fluid therapy can be monitored by observing urine output, Packed Cell Volume (PVC), Total Protein (TP, or Total Solids, TS), mucous membrane colour, and blood pressure among others. It is important to also observe for signs of oedema, such as pulmonary oedema or ascites. It should not be stopped until hydration of the patient has returned to normal and the patient is able to maintain a normal hydration status independently. | | Fluid therapy can be monitored by observing urine output, Packed Cell Volume (PVC), Total Protein (TP, or Total Solids, TS), mucous membrane colour, and blood pressure among others. It is important to also observe for signs of oedema, such as pulmonary oedema or ascites. It should not be stopped until hydration of the patient has returned to normal and the patient is able to maintain a normal hydration status independently. |
− |
| |
| | | |
| ==Special Considerations== | | ==Special Considerations== |
Line 116: |
Line 102: |
| **''Obstructive'' is seen when there is an obstruction to blood flow to a region of tissue. | | **''Obstructive'' is seen when there is an obstruction to blood flow to a region of tissue. |
| **''Distributive'' is seen when there is inappropriate vasodilation. This leads to changes in blood flow distribution between tissues. | | **''Distributive'' is seen when there is inappropriate vasodilation. This leads to changes in blood flow distribution between tissues. |
− |
| |
| | | |
| The first choice fluid in hypovolemic shock cases are ''isotonic crystalloid'' fluids and are given at a high flow rate. They are often administered as a rapid bolus followed by the high flow rate. In cardiogenic shock cases, often the patient is already in volume overload and so often treated with a diuretic. Obstructive shock is often treated by removal of the obstruction. | | The first choice fluid in hypovolemic shock cases are ''isotonic crystalloid'' fluids and are given at a high flow rate. They are often administered as a rapid bolus followed by the high flow rate. In cardiogenic shock cases, often the patient is already in volume overload and so often treated with a diuretic. Obstructive shock is often treated by removal of the obstruction. |
Line 127: |
Line 112: |
| | | |
| ====Intra-anaesthetic==== | | ====Intra-anaesthetic==== |
− | During an anaesthetic, normal homeostatic functions of the patient are altered and so fluid therapy should be initiated to any patient undergoing an anaesthetic to allow for maintained fluid balance. | + | During an anaesthetic, normal homeostatic functions of the patient are altered and so fluid therapy should be initiated to any patient undergoing an anaesthetic to allow for maintained fluid balance. During any procedure, glucose levels should be closely monitored, especially patients with diabetes, liver disease or paediatric patients. If necessary it is then possible to add glucose or dextrose to the fluid the patient is receiving. |
− | | |
− | During any procedure, glucose levels should be closely monitored, especially patients with diabetes, liver disease or paediatric patients. If necessary it is then possible to add glucose or dextrose to the fluid the patient is receiving. | |
| | | |
− | Some patients may develop an anaesthetic-induced hypotension from the side-effects of the agents used to induce and maintain anaesthesia. Fluids are therefore often given as a preventative measure. | + | Some patients may develop an anaesthetic-induced hypotension from the side-effects of the agents used to induce and maintain anaesthesia. Fluids are therefore often given as a preventative measure. If there is significant blood loss during a procedure, it is necessary to replace these losses, either using blood products or an appropriate fluid. |
− | | |
− | If there is significant blood loss during a procedure, it is necessary to replace these losses, either using blood products or an appropriate fluid. | |
| | | |
| As mentioned previously, it is also ideal to administer warm fluids to a patient to help maintain a normal body temperature during any procedure. This can be done by warming the fluids in a water bath, or wrapping the giving set line around a glove of warm water to help warm the fluids before they reach the patient. | | As mentioned previously, it is also ideal to administer warm fluids to a patient to help maintain a normal body temperature during any procedure. This can be done by warming the fluids in a water bath, or wrapping the giving set line around a glove of warm water to help warm the fluids before they reach the patient. |
Line 139: |
Line 120: |
| ====Post-anaesthetic==== | | ====Post-anaesthetic==== |
| If a patient has been receiving fluids during a procedure, it is often continued after until the patient is either stable and fully recovered from the anaesthetic. The length of time the fluids continue for after the procedure is dependent on the individual patient and the individual case. | | If a patient has been receiving fluids during a procedure, it is often continued after until the patient is either stable and fully recovered from the anaesthetic. The length of time the fluids continue for after the procedure is dependent on the individual patient and the individual case. |
− |
| |
| | | |
| ===Cardiac Disease=== | | ===Cardiac Disease=== |
Line 145: |
Line 125: |
| | | |
| ===Hepatic Disease=== | | ===Hepatic Disease=== |
− | Patients with hepatic diease often have alterations in protein levels due to reduced production, as well as changes in clotting factors. | + | Patients with hepatic diease often have alterations in protein levels due to reduced production, as well as changes in clotting factors. Hypoproteinemia will affect patients undergoing anaesthetics as many agents are protein bound so the reduction in protein means that more of the agent may be available. However, the hypoproteinemia may also be affected by the adminstration of certain fluid types so it is important to have a baseline so that the most appropriate fluid can be selected. |
− | | |
− | Hypoproteinemia will affect patients undergoing anaesthetics as many agents are protein bound so the reduction in protein means that more of the agent may be available. However, the hypoproteinemia may also be affected by the adminstration of certain fluid types so it is important to have a baseline so that the most appropriate fluid can be selected. | |
| | | |
| If there are any clotting disorders then it may be necessary to give blood products so that the missing clotting factors are available to the patient, while the underlying cause is diagnosed and treated. | | If there are any clotting disorders then it may be necessary to give blood products so that the missing clotting factors are available to the patient, while the underlying cause is diagnosed and treated. |
− |
| |
| | | |
| ===Central Nervous System Disease=== | | ===Central Nervous System Disease=== |
| Patients with head trama or increased intracranial pressure are particularly suscetible to insufficient or excessive fluid loading. It is therefore with care that fluids are administered and monitored. The choice of fluid is dependent on the other clinical signs of the patient such as haemodynamics. The status of the blood brain barrier is an important consideration in any patient and in the selection of fluid. However, fluids containing glucose should be avoided in these patients. | | Patients with head trama or increased intracranial pressure are particularly suscetible to insufficient or excessive fluid loading. It is therefore with care that fluids are administered and monitored. The choice of fluid is dependent on the other clinical signs of the patient such as haemodynamics. The status of the blood brain barrier is an important consideration in any patient and in the selection of fluid. However, fluids containing glucose should be avoided in these patients. |